United States

Zydus Cadila wins USFDA Nod for Hydroxychloroquine Sulphate Pills

Zydus Cadila
Chennai: Cadila Healthcare Ltd has received USFDA approval for hydroxychloroquine sulphate tabs in the strength of 200 mg.

The medicine falls under the DMARD (disease modifying anti-rheumatic drug) section, and is used in caring rheumatoid arthritis.

According to NDC Health, the sales of such pills in the US market in 2006 stood at $30 million.

Too much sleep can also double the risk of death

Washington, Sept 25: Researchers from the University of Warwick and University College London have found that while a lack of sleep doubles a person’s risk of death from cardiovascular diseases, too much of sleep can also have the same mortality effect from predominantly non-cardiovascular diseases.

Bacterial Meningitis Takes Away USF Student Life

Bacterial Meningitis Skin Rash
Tampa: A student at University of South Florida (USF) has died after getting infected with bacterial meningitis.
Rachel Futterman, 19-year-old, fell ill on Friday and was admitted into a hospital on the next day, where she was placed on life-support system and later passed away.

British heiress Stephanie Allen looking for a divorce; Lindsay Lohan blamed

Lindsay Lohan

UGA Odum School of Ecology Prof. To Handle WNV Case

West Nile VirusWest Nile virus has been widely studied after it affected New York City for t

FDA issues Warning on Baby Tummy Pain Medication

Baby TummyWashington: The Federal health agency has cautioned parents not to give infants a liquid herbal supplement promoted as a curative for colic and teething pain because various bottles proved positive for a parasite, which may have sickened a 6-week-old baby in Minnesota.

Pages